U.S. federal trademark · Serial No. 79034253 · Reg. No. 3312952
Pharmaceutical preparations based on human monoclonal antibodies for the treatment of cancer, AIDS (acquired immune deficiency syndrome) and other infections diseases, immune and autoimmune diseases, inflammatory diseases and cardiovascular diseases
Medical and scientific research, namely biological scientific research into human monoclonal antibodies and development of pharmaceutical products based on human monoclonal antibodies for the treatment of cancer, AIDS (acquired immune deficiency syndrome) and other infectious diseases, immune and autoimmune diseases, inflammatory diseases and cardiovascular diseases; chemical analysis; patent exploitation, namely, patent licensing; licensing of intellectual property in the field of medicine; computer programming, namely programming of computers for the collection and processing of medical data in medical scientific research, development and therapy with monoclonal antibodies
Biochemicals, namely monoclonal antibodies for in vivo or in vitro scientific research and development regarding cancer, AIDS (acquired immune deficiency syndrome), and other infectious diseases, immune and autoimmune diseases, inflammatory diseases and cardiovascular diseases
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.